(Q38246919)

English

Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor

scientific article published on January 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 September 2017

1 reference

Europe PubMed Central

Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor (English)

1 reference

Europe PubMed Central

1 September 2017

author name string

Campbell MJ

1

1 reference

Europe PubMed Central

1 September 2017

Esserman L

2

1 reference

Europe PubMed Central

1 September 2017

Byars NE

3

1 reference

Europe PubMed Central

1 September 2017

Allison AC

4

1 reference

Europe PubMed Central

1 September 2017

Levy R

5

1 reference

Europe PubMed Central

1 September 2017

publication date

1 January 1989

1 reference

Europe PubMed Central

1 September 2017

International Reviews of Immunology

1 reference

Europe PubMed Central

1 September 2017

4

1 reference

Europe PubMed Central

1 September 2017

4

1 reference

Europe PubMed Central

1 September 2017

251-270

1 reference

Europe PubMed Central

1 September 2017

Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044782

21 January 2018

Somatic mutation in human B-cell tumors

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044782

21 January 2018

Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044782

21 January 2018

Antibodies to idiotypes of isologous immunoglobulins

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044782

21 January 2018

Myeloma proteins as tumor-specific transplantation antigens

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044782

21 January 2018

Syngeneic antiidiotypic immune responses to a B cell lymphoma. Comparison between heavy chain hypervariable region peptides and intact Ig as immunogens

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044782

21 January 2018

Tumor Immunity Induced by Preimmunization With BALB/c Mouse Myeloma Protein2

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044782

21 January 2018

Protective and cellular immune responses to idiotypic determinants on cells from a spontaneous lymphoma of NZB-NZW F1 mice

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044782

21 January 2018

An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044782

21 January 2018

Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044782

21 January 2018

Indomethacin enhancement of spleen-cell responsiveness to mitogen stimulation in tumorous mice

1 reference

https://api.crossref.org/works/10.3109%2F08830188909044782

21 January 2018

Identifiers

10.3109/08830188909044782

1 reference

Europe PubMed Central

1 September 2017

1 reference

Europe PubMed Central

1 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38246919&oldid=2163460409"